Jan N. Basile, MD, FACP, FASH, FAHA
Professor of Medicine
Division of Cardiology
Medical University of South Carolina
Ralph H Johnson VA Medical Center
Previous Vice-Chair of Clinical Programs AHA Council of Hypertension
US National Leader SURPASS-CVOT
Charleston, SC

Dr. Jan N. Basile earned his medical degree in 1978 from the Medical College of Virginia in Richmond. He then completed his internship and residency at the Medical University of South Carolina (MUSC) in Charleston, where he was also Chief Resident. He is board certified in internal medicine and is a Fellow of the American College of Physicians (FACP), the American Society of Hypertension (FASH), and the American Heart Association (FAHA). For many years he served on the American Society of Hypertension (ASH) Board of Directors and has served within the AHA as Vice-Chair of Clinical Programs on the Council of Hypertension.

His honors and awards include the MUSC School of Medicine Excellence in Teaching award, the Golden Apple award, and, in 2014, he was the first recipient of the SC Department of Health and Environmental Control Hypertension Physician of the Year award. In 2019, he received the Marvin Moser Clinical Hypertension Award from the American Heart Association Council on Hypertension. He was President of the Southern Medical Association from 2008-2009.

Currently, he is Professor of Medicine at MUSC in the Division of Cardiology. He spent 31 years at the Ralph H Johnson VA Medical Center while faculty at MUSC, having retired from federal service as Chief of Primary Care in 2009. He remains a volunteer at the VA, his 45th year at that hospital. At MUSC, he continues to teach all 3rd year medical students clinical hypertension during their 3rd year core medicine rotation and currently sees clinical patients enrolled in research trials on the role of renal denervation in controlling hypertension.

Dr. Basile’s career research interests include outcome-based clinical trials involving hypertension, lipid disorders, and diabetes. He has been involved in many large hypertension trials that have defined how we treat hypertension including the NHLBI sponsored ALLHAT, ACCORD, SPRINT and SPRINT-MIND trials. In addition, he has been a principal investigator for the ACCOMPLISH, VALUE, ONTARGET, and TRANSCEND trials. Most recently, he has been involved in diabetes outcome trials with GLP1RA's including REWIND and is the US National Leader for the SURPASS-CV Outcome Trial comparing Dulaglutide with the dual-agonist Tirzepatide.

Dr Basile was a contributing reviewer of the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) and the 2017 ACC-AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. He has published more than 400 original papers, abstracts, and book chapters, as well as a textbook, Hot Topics: Hypertension. He continues to be a contributing author for the hypertension section of “Up To Date”.

Silvio E. Inzucchi, MD
Professor of Medicine, Endocrinology
Clinical Director, Section of Endocrinology
Director, Yale Diabetes Center
Director, Endocrinology & Metabolism Fellowship
Director, Yale Affiliated Hospitals
Yale School of Medicine
New Haven, CT

Dr. Silvio E. Inzucchireceived his undergraduate degree from Fordham University in New York City and his M.D. degree from Harvard Medical School in Boston, Massachusetts. He completed his residency in Internal Medicine and his post-doctoral Fellowship in Endocrinology and Metabolism at Yale-New Haven Hospital, in New Haven, Connecticut, USA. He is currently Professor of Medicine at the Yale University School of Medicine in New Haven, where he serves as Clinical Chief of the Section of Endocrinology, Medical Director of the Yale Diabetes Center, and Program Director of the Endocrinology & Metabolism Fellowship.

Dr. Inzucchi has been an invited lecturer both nationally and internationally on many topics, most pertaining to clinical diabetes management. He has authored or co-authored more than 500 manuscripts, chapters, monographs, and abstracts, some published in the most prestigious medical journals, including the New England Journal of Medicine and JAMA. A former member of the editorial board of Diabetes Care and Associate Editor of the Journal of Clinical Endocrinology and Metabolism, Dr. Inzucchi served as co-chair of the writing group for the 2012 and 2015 ADA-EASD Position Statements on the Management of Hyperglycemia in Type 2 Diabetes.

His current research interests include pharmacological antihyperglycemic therapy in both the inpatient and outpatient settings; and the link between type 2 diabetes, insulin resistance, and cardiovascular complications. He has held leadership roles in several large clinical trials related to diabetes medications and their cardiovascular impact.

Eddie Needham, MD, FAAFP
Program Director and Academic Chairman
AdventHealth Winter Park Family Medicine Residency Program
Professor, Department of Family Medicine, Loma Linda University School of Medicine
Professor of Medicine, University of Central Florida College of Medicine
Clinical Associate Professor, Florida State University College of Medicine
Winter Park, FL

Dr. Eddie Needham is the Program Director and Academic Chairman for the AdventHealth Winter Park Family Medicine Residency Program in Winter Park, Florida. Additionally, he is Professor of Family Medicine at UCF College of Medicine and Professor of Family Medicine at Loma Linda University College of Medicine. He practices full-service family medicine providing care from “conception to resurrection”. He has taught family medicine for 30 years and was on the AdventHealth Physician Network Board of Managers for five years. He served as a physician in the US Army for seven years. In 2013, Dr. Needham received the Full-Time Florida Family Physician Educator award. He has previously received the AFMRD Gold Award as a Program Director in 2017, the GAFP Teacher of the Year in 2007 and the 1996 AAFP Parke-Davis Teacher awards. He has been a regular speaker at the America Academy of Family Physicians national meeting (FMX) since 2010 and has spoken internationally at the Emirates Family Medicine Society's annual conference in Dubai since 2018. It is his joy and passion to teach all students of medicine the wonders of the human body. He loves his wife of 34 years, his five adult children and two granddaughters, the wonder and surprise of fishing, and outdoor adventures with friends.

Anita L. Nelson, MD
Professor Emeritus, Obstetrics and Gynecology
David Geffen School of Medicine at UCLA
Clinical Professor Obstetrics and Gynecology
Western University of Health Sciences
Torrance, CA

Dr. Anita L. Nelson is a Professor Emeritus of Obstetrics and Gynecology at UCLA, and Obstetrics and Gynecology at COMP/COMP NW at the Western University of Health Sciences. For over 25 years, she has also been Medical Director of research for Essential Access Health. That group is one of the founding members of the NIH Contraceptive Network and has conducted Phase II thru Phase IV trials for a wide array of female and male contraceptive methods. Altogether she has been responsible for nearly $60 million of research grants, published over 200 articles in professional journals, 76 chapters, and over 125 abstracts. She has given over 3,000 CME lectures. She particularly enjoys teaching and advocating for reproductive justice.